Clinical Assessment of Bone Mass, Quality and Architecture J. A. KanisE. V. McCloskeyK. Pande Original Article Pages: S24 - S28
Calcium, Vitamin D and Vitamin K in the Prevention of Fractures due to Osteoporosis P. J. Meunier Original Article Pages: S48 - S52
How Should the Risk of Fracture in Postmenopausal Women be Assessed? P. D. Delmas Original Article Pages: S33 - S39
Treatment of Osteoporosis: Role of Bone-Forming Agents J.-Y. ReginsterV. HalkinC. Gosset Original Article Pages: S91 - S96
Cost-Effective Treatment Strategies for Osteoporosis L. J. Melton III Original Article Pages: S111 - S116
Risk Factors for Hip Fracture Not Related to Bone Mass and Their Therapeutic Implications B. Allolio Original Article Pages: S9 - S17
Determinants of Peak Bone Mass and Mechanisms of Bone Loss R. RizzoliJ.-P. Bonjour Original Article Pages: S17 - S23
Calcitonin, Bone-Active Isoflavones and Vitamin D Metabolites C. Gennari Original Article Pages: S81 - S90
What Can We Learn from Bone Biology for the Treatment for Osteoporosis? G. R. Mundy Original Article Pages: S40 - S47
An Assessment of Hormone Replacement Therapy to Prevent Postmenopausal Osteoporosis M. Dören Original Article Pages: S53 - S61
Bisphosphonates: Pharmacology, Mechanisms of Action and Clinical Uses R. G. G. RussellP. I. CroucherM. J. Rogers Original Article Pages: S66 - S80